SC&H Financial Advisors’s AbbVie ABBV Stock Holding History

SC&H Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$334K	Hold	1,327	–	–	0.04%	122
2026 Q1	$289K	Hold	1,327	–	–	0.04%	126
2025 Q4	$303K	Buy	1,327 +151	+13%	+$34.4K	0.05%	126
2025 Q3	$272K	Buy	1,176 +7	+0.6%	+$1.43K	0.04%	125
2025 Q2	$217K	Hold	1,169	–	–	0.04%	146
2025 Q1	$245K	Sell	1,169 -30	-3%	-$5.83K	0.05%	132
2024 Q4	$213K	Buy	1,199 +30	+3%	+$5.52K	0.04%	143
2024 Q3	$231K	Buy	1,169 +2	+0.2%	+$373	0.05%	138
2024 Q2	$200K	Buy	+1,167	New	+$193K	0.05%	141

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SC&H Financial Advisors's ABBV Position: Q2 2026 in Review

SC&H Financial Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 1,327 shares worth $334K. The position accounts for 0.04% of the portfolio, ranked #122.

SC&H Financial Advisors first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

SC&H Financial Advisors held 1,327 shares of AbbVie worth $334K as of Q2 2026.
SC&H Financial Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.04% of SC&H Financial Advisors's portfolio in Q2 2026, its #122 holding.
SC&H Financial Advisors first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SC&H Financial Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.